Which hedge funds own VRCA? VERRICA PHARMACEUTICALS INC, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in VRCA (VERRICA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $19.6m in total. The largest holder by portfolio weight is Cannell Capital LLC at 3.3% of its book. 3 exited: Marshall Wace, LLP, Squarepoint Ops LLC, Stonepine Capital Management, LLC.
8tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold VRCA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Cannell Capital LLC | Q2 2026 | 3.3% | $4.8m | 783,923 | 14% | added |
| Caligan Partners LP | Q2 2026 | 0.3% | $5.7m | 923,910 | 0% | held |
| Affinity Asset Advisors, LLC | Q2 2026 | 0.2% | $4.3m | 707,338 | 0% | held |
| Verdad Advisers, LP | Q2 2026 | 0.1% | $141.2k | 23,069 | 91% | added |
| Armistice Capital, LLC | Q2 2026 | 0.1% | $2.6m | 426,304 | -18% | reduced |
| Boothbay Fund Management, LLC | Q2 2026 | 0.0% | $1.7m | 280,734 | 0% | held |
| Dafna Capital Management LLC | Q2 2026 | 0.0% | $145.3k | 23,750 | -85% | reduced |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $249.8k | 40,825 | -19% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace, LLP | 0.0% | $743.2k |
| Squarepoint Ops LLC | 0.0% | $397.9k |
| Stonepine Capital Management, LLC | 10.2% | $527.6k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of VRCA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $19.8m |
| Q1 2026 | 12 | $19.5m |
| Q4 2025 | 1 | $219.4k |
| Q3 2025 | 1 | $125.8k |
| Q2 2025 | 1 | $46.2k |
| Q4 2024 | 1 | $163.3k |
| Q3 2024 | 1 | $214.5k |
| Q2 2024 | 1 | $331.9k |
| Q3 2023 | 1 | $265.0k |
| Q2 2023 | 1 | $919.0k |
| Q1 2023 | 2 | $388.9k |
| Q4 2022 | 1 | $430.0k |
| Q3 2022 | 2 | $2.1m |
| Q2 2022 | 2 | $1.5m |
| Q4 2019 | 1 | $221.0k |
| Q2 2019 | 1 | $1.7m |
Counts every tracked manager that disclosed VRCA in that quarter's filing, including managers that have since stopped filing.